Jun 08, 2020
Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease
May 28, 2020
Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine® in Respiratory Illness in Patients with COVID-19 at Singapore General Hospital
May 05, 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Mar 24, 2020
Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine® in Patients with COVID-19 Associated Respiratory Illness
Nov 27, 2019
The Erythropoietin Stimulating Agents Market in Latin America (2019-2027): Data on Epoetin-Alfa, Epoetin-Beta, Epoetin-Theta, Darbepoetin-Alfa, and Other ESAs
Oct 07, 2019
Helixmith shows long-term safety and efficacy of VM202 for painful DPN patients in DPN phase 3-1b extension study
Sep 20, 2019
Global Neutropenia Treatment Market Report 2019-2027
Sep 19, 2019
Partner Therapeutics Receives Orphan Drug Designation for Leukine® (sargramostim)
Sep 16, 2019
China Recombinant Human Thrombopoietin Markets, 2013-2017, 2017-2018 & 2019-2023
Jun 26, 2019
Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) Overview 2019: An Oral Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1), VEGFR-2, & VEGFR-3
Jun 24, 2019
Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist
Apr 08, 2019
IGF Oncology Appoints Gary G. Altman, Ph.D., as Chief Executive Officer
Mar 27, 2019
BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
Mar 25, 2019
AlzeCure to Present at International Scientific Conference
Feb 28, 2019
Patient access to cost-effective treatments increased with launch of new biosimilar in Canada
Feb 17, 2019
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients
Jan 14, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat(TM) for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital
Sep 28, 2018
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration
Sep 21, 2018
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Aug 07, 2018
BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization